| 1 | [SID26748398] | Active | | | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) [AID880, Type: confirmatory] | RGS12 [Homo sapiens] [gi:3290016] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26748398 | | CID | 204 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) | | AID | 880 | | BioAssay type | confirmatory | | Target | RGS12 [Homo sapiens] [gi:3290016] | | PubMed | | | Data Table |  |
|
| 2 | [SID8149886] | Unspecified | | | Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) [AID1583, Type: other] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) | | AID | 1583 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID8149886] | Unspecified | | | Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) [AID1603, Type: other] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) | | AID | 1603 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID8149886] | Unspecified | | | Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) [AID1604, Type: other] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) | | AID | 1604 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID8149886] | Unspecified | | | Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1) [AID1605, Type: other] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1) | | AID | 1605 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID8149886] | Unspecified | | | Screen for compounds that induce the human heat shock transcriptional response (HSEluc) [AID1611, Type: other] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Screen for compounds that induce the human heat shock transcriptional response (HSEluc) | | AID | 1611 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID8149886] | Unspecified | | | Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) [AID1612, Type: other] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) | | AID | 1612 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID8149886] | Unspecified | | | Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) [AID1613, Type: other] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) | | AID | 1613 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID8149886] | Unspecified | | | Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) [AID1614, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) | | AID | 1614 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID8149886] | Unspecified | | | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH) [AID1616, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH) | | AID | 1616 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID8149886] | Unspecified | | | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) [AID1593, Type: other] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) | | AID | 1593 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID103717446] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103717446 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans | | AID | 588211 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 13 | [SID103717446] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103717446 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents | | AID | 588212 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 14 | [SID103717446] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents [AID588213, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103717446 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents | | AID | 588213 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 15 | [SID103717446] | Unspecified | | | Induction of NGF production in rat C6 cells at 20 uM after 24 hrs by ELISA relative to untreated control [AID589667, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103717446 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Induction of NGF production in rat C6 cells at 20 uM after 24 hrs by ELISA relative to untreated control | | AID | 589667 | | BioAssay type | Literature | | Target | | | PubMed | 21353549 | | Data Table |  |
|
| 16 | [SID103717446] | Unspecified | | | Cytotoxicity against rat C6 cells assessed as viable cells at 20 uM after 24 hrs by MTT assay [AID589668, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103717446 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against rat C6 cells assessed as viable cells at 20 uM after 24 hrs by MTT assay | | AID | 589668 | | BioAssay type | Literature | | Target | | | PubMed | 21353549 | | Data Table |  |
|
| 17 | [SID8149886] | Unspecified | | | Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) [AID1599, Type: other] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 8149886 | | CID | 204 | | Outcome | Unspecified | | BioAssay | Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) | | AID | 1599 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID26665884] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 19 | [SID26665884] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 20 | [SID26748398] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26748398 | | CID | 204 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 21 | [SID26748398] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26748398 | | CID | 204 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 22 | [SID26665884] | Inactive | | | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) [AID880, Type: confirmatory] | RGS12 [Homo sapiens] [gi:3290016] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) | | AID | 880 | | BioAssay type | confirmatory | | Target | RGS12 [Homo sapiens] [gi:3290016] | | PubMed | | | Data Table |  |
|
| 23 | [SID26665884] | Inactive | | | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity [AID652163, Type: screening] | S100A4 [Homo sapiens] [gi:47496637] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652163 | | BioAssay type | screening | | Target | S100A4 [Homo sapiens] [gi:47496637] | | PubMed | | | Data Table |  |
|
| 24 | [SID26665884] | Inactive | Potency | | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 25 | [SID26665884] | Inactive | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 26 | [SID26665884] | Inactive | | | High Throughput Screening for Cocaine Antagonists: Primary Screen [AID449768, Type: screening] | dopamine transporter [Homo sapiens] [gi:7108463] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | High Throughput Screening for Cocaine Antagonists: Primary Screen | | AID | 449768 | | BioAssay type | screening | | Target | dopamine transporter [Homo sapiens] [gi:7108463] | | PubMed | | | Data Table |  |
|
| 27 | [SID26665884] | Inactive | | | High Throughput Screening for Cocaine Antagonists: Primary Screen [AID449768, Type: screening] | dopamine transporter [Homo sapiens] [gi:7108463] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | High Throughput Screening for Cocaine Antagonists: Primary Screen | | AID | 449768 | | BioAssay type | screening | | Target | dopamine transporter [Homo sapiens] [gi:7108463] | | PubMed | | | Data Table |  |
|
| 28 | [SID26665884] | Inactive | | | High Throughput Screening for Cocaine Antagonists: Primary Screen [AID449768, Type: screening] | dopamine transporter [Homo sapiens] [gi:7108463] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | High Throughput Screening for Cocaine Antagonists: Primary Screen | | AID | 449768 | | BioAssay type | screening | | Target | dopamine transporter [Homo sapiens] [gi:7108463] | | PubMed | | | Data Table |  |
|
| 29 | [SID26665884] | Inactive | | | High Throughput Screening for Cocaine Antagonists: Primary Screen [AID449768, Type: screening] | dopamine transporter [Homo sapiens] [gi:7108463] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | High Throughput Screening for Cocaine Antagonists: Primary Screen | | AID | 449768 | | BioAssay type | screening | | Target | dopamine transporter [Homo sapiens] [gi:7108463] | | PubMed | | | Data Table |  |
|
| 30 | [SID26665884] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] | | PubMed | | | Data Table |  |
|
| 31 | [SID26748398] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26748398 | | CID | 204 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 32 | [SID26748398] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26748398 | | CID | 204 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 33 | [SID26665884] | Inactive | Potency | | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 34 | [SID26665884] | Inactive | Potency | | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 35 | [SID103914702] | Inactive | | | Screening small molecules to find regulators of human embryonic stem cell survival. [AID493140, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103914702 | | CID | 204 | | Outcome | Inactive | | BioAssay | Screening small molecules to find regulators of human embryonic stem cell survival. | | AID | 493140 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID121362640] | Inactive | | | A screen for compounds that inhibit liver stage malaria [AID624349, Type: other] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 121362640 | | CID | 204 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit liver stage malaria | | AID | 624349 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID92124969] | Inactive | | | A screen for compounds that inhibit liver stage malaria [AID624349, Type: other] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 92124969 | | CID | 204 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit liver stage malaria | | AID | 624349 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID92307726] | Inactive | | | A screen for compounds that inhibit liver stage malaria [AID624349, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 92307726 | | CID | 204 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit liver stage malaria | | AID | 624349 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID26665884] | Inactive | | | Small Molecules that selectively kill Giardia lamblia: qHTS [AID540267, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | Small Molecules that selectively kill Giardia lamblia: qHTS | | AID | 540267 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID26665884] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID26665884] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity [AID588334, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity | | AID | 588334 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID26665884] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID26665884] | Inactive | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID26665884] | Inactive | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID26665884] | Inactive | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID26665884] | Inactive | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID26665884] | Inactive | IC50 | | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 [AID588727, Type: confirmatory] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 | | AID | 588727 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID26665884] | Inactive | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID26665884] | Inactive | Potency | | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID26665884] | Inactive | | | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602247, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26665884 | | CID | 204 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602247 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|